0000950170-23-048775.txt : 20230919 0000950170-23-048775.hdr.sgml : 20230919 20230919160627 ACCESSION NUMBER: 0000950170-23-048775 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230915 FILED AS OF DATE: 20230919 DATE AS OF CHANGE: 20230919 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: LaMond Stephen J CENTRAL INDEX KEY: 0001951073 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39951 FILM NUMBER: 231263746 MAIL ADDRESS: STREET 1: 3350 W BAYSHORE ROAD STREET 2: SUITE 100 CITY: PALO ALTO STATE: CA ZIP: 94303 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Peak Bio, Inc. CENTRAL INDEX KEY: 0001834645 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 852448157 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 4900 HOPYARD ROAD, SUITE 100 CITY: PLEASANTON STATE: CA ZIP: 94588 BUSINESS PHONE: (925) 463-4800 MAIL ADDRESS: STREET 1: 4900 HOPYARD ROAD, SUITE 100 CITY: PLEASANTON STATE: CA ZIP: 94588 FORMER COMPANY: FORMER CONFORMED NAME: Ignyte Acquisition Corp. DATE OF NAME CHANGE: 20201202 4 1 ownership.xml 4 X0508 4 2023-09-15 0001834645 Peak Bio, Inc. PKBO 0001951073 LaMond Stephen J 4900 HOPYARD ROAD SUITE 100 PLEASANTON CA 94588 true true false false See Remarks false Common Stock 2023-09-15 4 P false 26000 A 26000 D Common Stock 2023-09-18 4 P false 2500 A 28500 D On September 15, 2023, Dr. Stephen LaMond purchased a total of 26,000 shares of the Company's Common Stock at prices ranging from $0.275 per share to $0.43 per share. On September 18, 2023, Dr. Stephen LaMond purchased a total of 2,500 shares of the Company's Common Stock at prices ranging from $0.23 per share to $0.29 per share. Interim Chief Executive Officer /s/ Dr. Stephen LaMond 2023-09-19